Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.


Updates from The Motley Fool

Latest updates on ChemoCentryx from Fool.com.
This Week in Biotech

The buddy system works well for three companies this week while three others take a dive followin...



Stock Performance

View Interactive CCXI Charts
Sponsored by

Key Data Points

Primary metrics and data points about ChemoCentryx.
Current Price: $7.08
Prev Close: $7.02
Open: $7.01
Bid: $5.30
Ask: $8.20
Day's Range: $6.72 - $7.18
52wk Range: $3.95 - $9.10
Volume: 118,143
Avg Vol 83,616
Market Cap: $341M
P/E (ttm): -10.97
EPS (ttm): ($0.64)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ChemoCentryx.
CAPS Rating 3 out of 5
 
47 Outperform
3 Underperform
CAPS All Stars
 
13 Outperform
2 Underperform

How do you think ChemoCentryx will perform against the market?



You pick for ChemoCentryx is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Thomas J. Schall, CEO

38% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ChemoCentryx.

Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers